Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study.
RSV
age
surveillance
Journal
The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424
Informations de publication
Date de publication:
05 Apr 2024
05 Apr 2024
Historique:
received:
31
12
2023
revised:
16
03
2024
accepted:
29
03
2024
medline:
8
4
2024
pubmed:
8
4
2024
entrez:
7
4
2024
Statut:
aheadofprint
Résumé
We aimed to study whether the percentwise age distribution of RSV cases changes over time during annual epidemics. We used surveillance data (2008-2019) from the Netherlands, Lyon (France), Portugal, Singapore, Ecuador, South Africa, and New Zealand. In each country, every season was divided into "epidemic quarters", i.e. periods corresponding to each quartile of RSV cases. Multinomial logistic regression models were fitted to evaluate whether the likelihood of RSV cases being aged <1 or ≥5 years (vs. 1 to <5) changed over time within a season. In all countries, RSV cases were significantly more likely to be aged <1 year in the 4 The age profile of RSV cases shifts within a season, with infants and adolescents, adults, and the elderly constituting a higher proportion of cases in the later phases of annual epidemics. These findings may have implications for RSV prevention policies with newly approved vaccines.
Identifiants
pubmed: 38583722
pii: S0163-4453(24)00088-4
doi: 10.1016/j.jinf.2024.106154
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106154Informations de copyright
Copyright © 2024. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: M.B. and R.K. are Sanofi employees and may hold shares and/or stock options in the company. J.P. reports that Nivel has received RSV research grants from the Foundation for Influenza Epidemiology and Sanofi. The remaining authors declare no competing interests. Conflict of interest M.B. and R.K. are Sanofi employees and may hold shares and/or stock options in the company. J.P. reports that Nivel has received RSV research grants from the Foundation for Influenza Epidemiology and Sanofi. The remaining authors declare no competing interests.